VERO
Get informed when a big investor buys or sells
+ FollowUndervalued by 500.3% based on the discounted cash flow analysis.
| Market cap | $578,187.00 |
|---|---|
| Enterprise Value | $5.21 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-66.28 |
| Beta | -0.06 |
| Outstanding Shares | 1,859,000 |
| P/E Ratio | -0.01 |
|---|---|
| PEG | -0.01 |
| Price to Sales | 0.02 |
| Price to Book Ratio | 0.08 |
| Enterprise Value to Revenue | 0.17 |
| Enterprise Value to EBIT | -0.14 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.72 |
| Debt to Equity | 3.35 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 6.90%▼ 0.59% |
|---|---|
| Total Invested | $189,499▼ 40.84% |
| Investors Holding | 9▼ 1.00% |
No data
Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic technologies, and reach in over 60 countries and 29 direct markets. Venus C...